弥散磁共振成像预测慢性肾脏病及肾移植受者肾功能下降
这项前瞻性研究纳入197例患者(43例慢性肾脏病,154例肾移植受者),在肾活检一周内行弥散加权磁共振成像测量皮髓质表观弥散系数差值(ΔADC),中位随访2.2年。ΔADC为负的患者快速肾功能下降或透析风险增加5.4倍(95%CI 2.29-12.58);校正基线肾功能和蛋白尿后,低ADC仍预测显著肾功能丧失,风险比4.62(95%CI 1.56-13.67)。
要点
- ΔADC为负与快速肾功能下降或透析风险增加相关,风险为5.4倍(95%CI 2.29-12.58)。
- 校正基线年龄、性别、eGFR和蛋白尿后,低ADC仍独立预测肾功能丧失,HR 4.62(95%CI 1.56-13.67)。
- 弥散加权磁共振成像测量的ΔADC或可作为慢性肾脏病和肾移植受者肾功能下降的无创预测指标。
核心结论
- 低ΔADC可预测原发肾脏病或肾移植受者的肾功能下降和透析启动,且独立于基线肾功能和蛋白尿。
研究设计与样本
- 前瞻性研究,纳入197例患者,其中43例慢性肾脏病(eGFR 55ml/min/1.73m2)和154例肾移植受者(eGFR 53ml/min/1.73m2)。
- 患者在肾活检一周内接受肾脏活检和弥散加权磁共振成像,中位随访2.2年并测量实验室参数。
主要发现
- ΔADC为负的患者快速肾功能下降或透析风险为5.4倍(95%CI 2.29-12.58)。
- 校正基线肾功能和蛋白尿后,低ADC仍预测显著肾功能丧失,风险比4.62(95%CI 1.56-13.67),独立于基线年龄、性别、eGFR和蛋白尿。
关键数值与推荐
- 主要结局为随访期间快速肾功能下降(eGFR下降超过30%)或透析启动。
- ΔADC为负的患者快速肾功能下降或透析风险为5.4倍(95%CI 2.29-12.58)。
- 校正后低ADC预测肾功能丧失的风险比为4.62(95%CI 1.56-13.67)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Kidney cortical interstitial fibrosis is highly predictive of kidney prognosis and is currently assessed by evaluation of a biopsy. Diffusion-weighted magnetic resonance imaging is a promising non-invasive tool to evaluate kidney fibrosis. We recently adapted diffusion-weighted imaging sequence for discrimination between the kidney cortex and medulla and found that the cortico-medullary difference in apparent diffusion coefficient (ΔADC) correlated with histological interstitial fibrosis. Here, we assessed whether ΔADC as measured with diffusion-weighted magnetic resonance imaging is predictive of kidney function decline and dialysis initiation in chronic kidney disease (CKD) and patients with a kidney allograft in a prospective study encompassing 197 patients. We measured ΔADC in 43 patients with CKD (estimated GFR (eGFR) 55ml/min/1.73m2) and 154 patients with a kidney allograft (eGFR 53ml/min/1.73m2). Patients underwent a kidney biopsy and diffusion-weighted magnetic resonance imaging within one week of biopsy; median follow-up of 2.2 years with measured laboratory parameters. The primary outcome was a rapid decline of kidney function (eGFR decline over 30% or dialysis initiation) during follow up. Significantly, patients with a negative ΔADC had 5.4 times more risk of rapid decline of kidney function or dialysis (95% confidence interval: 2.29-12.58). After correction for kidney function at baseline and proteinuria, low ADC still predicted significant kidney function loss with a hazard ratio of 4.62 (95% confidence interval 1.56-13.67) independent of baseline age, sex, eGFR and proteinuria. Thus, low ΔADC can be a predictor of kidney function decline and dialysis initiation in patients with native kidney disease or kidney allograft, independent of baseline kidney function and proteinuria.
引用
- Berchtold L, Crowe LA, Combescure C, et al. Diffusion-magnetic resonance imaging predicts decline of kidney function in chronic kidney disease and in patients with a kidney allograft. Kidney Int. 2022. PMID: 35031327. doi:10.1016/j.kint.2021.12.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。